The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for JJ Bourguignon


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.EBI
University of Strasbourg
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.EBI
Universidade Federal Do Rio De Janeiro
Synthesis,s1,s2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes.EBI
National and Kapodistrian University of Athens
Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.EBI
Umr Uds/Cnrs 7200
Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.EBI
Louis Pasteur University
Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling.EBI
Magna Graecia University of Catanzaro
Aminopyridazines as acetylcholinesterase inhibitors.EBI
Louis Pasteur University
5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists.EBI
Louis Pasteur University
9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.EBI
Upr 421 Du Cnrs
New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.EBI
University of Strasburg
 
SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndromeEBI
TBA
Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.EBI
Université
Heterocyclic bis-cations as starting hits for design of inhibitors of the bifunctional enzyme histidine-containing protein kinase/phosphatase from Bacillus subtilis.EBI
University of Strasburg
Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compound.EBI
TBA
Design and synthesis of 3-aminophthalazine derivatives and structural analogues as PDE5 inhibitors: anti-allodynic effect against neuropathic pain in a mouse model.EBI
University of Strasbourg
Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of a phosphodiesterase 4 inhibitor.EBI
Umr Cnrs 7081
Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies.EBI
Centre De Neurochimie Du Cnrs
Synthesis and structure-activity relationships of a series of aminopyridazine derivatives of gamma-aminobutyric acid acting as selective GABA-A antagonists.EBI
TBA
Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues.EBI
Centre De Neurochimie Du Cnrs